Skip to content

Feasibility of Cognitive-Behavior Group Therapy for Depressive Disorders: Randomized Controlled Trial

Feasibility of Cognitive-Behavior Group Therapy for Depressive Disorders: Randomized Controlled Trial - CoGrout Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048877
Enrollment
40
Registered
2022-09-20
Start date
2022-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Interventions

Cognitive-Behavioral Group Therapy Treatment as usual

Sponsors

Keio University, School of Medicine
Lead Sponsor
1. Ichigaya Himorogi Clinic 2. Shinjuku Yoyogi Kokoro no Labo Clinic 3. Hamadayama Metal Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects with DSM-V Depression Disorder 2. Subjects with CGIS(Clinical Global Impression)score is 3(mildly ill ), 4(Moderately ill), or 5(Markedly ill) 3. Subjects between the ages of 18 and 70 at the time of screening 4. Subjects ca obtain written consent

Exclusion criteria

Exclusion criteria: 1. No alcohol or substance use disorder in 24 months prior to the screening. 2. No history of concurrent manic, or psychotic episodes. 3. No other primary Axis I Disorders in 6 months prior to the screening. 4. No comorbid antisocial personality disorder. 5. No serious suicidal ideation at screening. 6. Unlikely to attend more than 4 visits during the 8-week trial phase. 7. No treatment of CBT or CBGT within the last year prior to the screening. 8. No organic brain lesions or major cognitive deficits. 9. No severe or unstable medical illness at screening. 10. Other relevant reasons decided by the CogGrout study principal investigator.

Design outcomes

Primary

MeasureTime frame
Depressive symptom: PHQ-9(Patient Health Questionnaire

Secondary

MeasureTime frame
-Anxiety symptom: GAD-7(Generalized Anxiety Disorder) -Self-Efficacy: GSES(General Self-Efficacy Scale) -Personal Recovery: QPR-J(Japanese version of the Questionnaire about the Process of Recovery) -Coping stress: CISS(Coping Inventory for Stressful Situation) -QOL: WHO-QOL -Disability: SDS(Sheehan Disability Scale) -Others: Questionnaire on the use of CBT skills after participating in the group.

Countries

Japan

Contacts

Public ContactMiyuki Tajima

Keio University School of Medicine Department of Neuropsychiatry

taji0808@gmail.com03-5363-3829

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026